Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | TOP1 | P11387 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1626385 | 1.00 | TERT (0.53) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL9955160 | 1.00 | TERT (0.53) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL630531 | 1.00 | TERT (0.53) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL17685248 | 0.98 | TERT (0.51) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL20608643 | 0.95 | ALDH1A1 (0.57) | PPARGPPARDPPARAMAPTBLM | |
| SCHEMBL1679200 | 0.93 | TERT (0.50) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL29393904 | 0.93 | TERT (0.50) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL7135799 | 0.93 | TERT (0.50) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL2424414 | 0.92 | PPARG (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| Behenic Acid SCHEMBL2163391 | 0.92 | PPARG (0.68) | TERTPTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7928090-B2 | External preparation composition | LION CORPORATION (JP) | 2011-04-19 | — | — | US | claimed |
| US-20100074856-A1 | EXTERNAL PREPARATION COMPOSITION | LION CORPORATION (JP) | 2010-03-25 | — | — | US | claimed |
| US-20250043093-A1 | POROUS PARTICLE, COSMETIC COMPOSITION, AND PRODUCTION METHOD FOR POROUS PARTICLE | DAICEL CORPORATION (JP) | 2025-02-06 | — | — | US | disclosed |
| EP-4455198-A1 | POROUS PARTICLE, COSMETIC COMPOSITION, AND PRODUCTION METHOD FOR POROUS PARTICLE | Daicel Corporation (JP) | 2024-10-30 | — | — | EP | disclosed |
| US-20190008747-A1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | Hayashibara Co., Ltd. (JP) | 2019-01-10 | — | — | US | disclosed |
| CN-103319720-B | Organopolysiloxane and manufacture method thereof, cosmetic containing organopolysiloxane | SHIN-ETSU CHEMICAL INDUSTRY CO., LTD. (JP) | 2016-03-09 | — | — | CN | disclosed |
| EP-2659899-A2 | Lipophilic carrier composition for solubilizing lipophilic bioactive botanical extracts, methods of solubilizing lipophilic bioactive botanical extracts, and methods of using solubilized lipophilic bioactive botanical extracts | Innovacos Corporation (US) | 2013-11-06 | — | — | EP | disclosed |
| US-20110223223-A1 | POWDER COSMETIC MATERIAL | HYOGO PREFECTURE (JP) | 2011-09-15 | — | — | US | disclosed |
| US-6156324-A | Compositions for cosmetics and cosmetics | MIYOSHI KASEI, INC. (JP) | 2000-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100074856-A1 | EXTERNAL PREPARATION COMPOSITION | GLA, COLGALT1, DPM1 | TERT 2708/4885PTPN1 3810/4885PPARG 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.